On Monday, February 9, the next meeting of the AOTMiT Transparency Council.
AOTMiT: Transparency Council on lung cancer, cystic fibrosis and perinatal care, among others
Published Feb. 6, 2026 07:27
The agenda includes:
1 Prepare a position paper on the evaluation of the drug Opdivo (nivolumabum) under the drug program. B.6. "Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)".
2 Prepare a position paper on the evaluation of the drug Alyftrek (deutivacaftor + tezacaftorum + vanzacaftor) under the drug program B.112. "Treatment of patients with cystic fibrosis (ICD-10: E84)".
3 Prepare an opinion on the draft health policy program of the local government unit "Bet on health - a program of prevention of cognitive disorders for people with risk factors for diseases of the nervous system in the age range of 45-65 years residing in the Lublin province".
4. Prepare an opinion on the draft health policy program of the local government unit "Health policy program in the field of pre-natal/perinatal care of pregnant women titled County Birth School" (Wroclaw district).
5 Prepare an opinion on the draft health policy program of the local government unit "Health policy program in the field of therapeutic rehabilitation of children and young people in the city of Wodzislaw Slaski for 2026-2032".
Source: AOTMiT
